Kyle Perry
Impact in
-
- Lymphoma Diagnosis and Treatment
- Tumors and Oncological Cases
- Oncology top 10%
- Viral-associated cancers and disorders
- Vascular Tumors and Angiosarcomas
Papers in
-
- Sarcoma Diagnosis and Treatment 9
-
- Soft tissue tumor case studies 5
- Urologic and reproductive health conditions 4
- Bone Tumor Diagnosis and Treatments 3
- Co-authors
- Lynette M. Smith (2 shared papers)Julie M. Vose (2 shared papers)Timothy C. Greiner (2 shared papers)Dennis D. Weisenburger (2 shared papers)Christine P. Hans (2 shared papers)Philip J. Bierman (2 shared papers)Kai Fu (2 shared papers)Wing C. Chan (2 shared papers)
- Journals
- Diagnostic Cytopathology (5 papers)Modern Pathology (4 papers)Journal of Clinical Oncology (2 papers)Histopathology (2 papers)Human Pathology (2 papers)
- Partner nations
- United StatesSwedenCanada
In The Last Decade
Kyle Perry
24 papers receiving 599 citations
Peers
Comparison fields: 5 of 51
- Pathology and Forensic Medicine 304
- Oncology 206
- Genetics 77
- Rheumatology 101
- Neurology 78
Countries citing papers authored by Kyle Perry
This map shows the geographic impact of Kyle Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Perry more than expected).
Fields of papers citing papers by Kyle Perry
This network shows the impact of papers produced by Kyle Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Perry. The network helps show where Kyle Perry may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle Perry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 240 | |
| 2 | 2017 | 92 | |
| 3 | 2018 | 48 | |
| 4 | 2017 | 38 | |
| 5 | 2011 | 36 | |
| 6 | 2008 | 34 | |
| 7 | 2014 | 33 | |
| 8 | 2020 | 26 | |
| 9 | 2011 | 15 | |
| 10 | 2018 | 13 | |
| 11 | 2019 | 8 | |
| 12 | 2021 | 4 | |
| 13 | 2012 | 4 | |
| 14 | 2016 | 4 | |
| 15 | 2021 | 3 | |
| 16 | 2024 | 2 | |
| 17 | 2020 | 2 | |
| 18 | 2011 | 2 | |
| 19 | 2009 | 2 | |
| 20 | 2021 | 1 |
About Kyle Perry
Kyle Perry is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology, Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Oncology, having authored 29 papers that have together received 611 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Cardiac tumors and thrombi (5 papers), Soft tissue tumor case studies (5 papers), Urologic and reproductive health conditions (4 papers), Bone Tumor Diagnosis and Treatments (3 papers), Tumors and Oncological Cases (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Vascular Tumors and Angiosarcomas (3 papers). The work is most often cited by research in Pathology and Forensic Medicine (304 citations), Oncology (206 citations), Genetics (77 citations), Rheumatology (101 citations) and Neurology (78 citations). Kyle Perry has collaborated with scholars based in United States, Sweden and Canada. Frequent co-authors include Lynette M. Smith, Julie M. Vose, Timothy C. Greiner, Dennis D. Weisenburger, Christine P. Hans, Philip J. Bierman, Kai Fu, Wing C. Chan, R. Gregory Bociek and Jamés O. Armitage. Their work appears in journals such as Diagnostic Cytopathology, Modern Pathology, Journal of Clinical Oncology, Histopathology and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.